Mandal Kaushik, Torsney Evelyn, Poloniecki Jan, Camm A John, Xu Qingbo, Jahangiri Marjan
Department of Cardiothoracic Surgery, St. George's Hospital and Medical School, London, United Kingdom.
Ann Thorac Surg. 2005 Mar;79(3):865-71; discussion 871. doi: 10.1016/j.athoracsur.2004.08.018.
Atrial fibrillation is a common arrhythmia, after cardiac surgery. Reperfusion injury and inflammation associated with cardiac surgery are thought to be involved in its pathogenesis. We hypothesized that cytoprotective effects associated with heat shock protein 70 (HSP70) could counteract these proarrhythmic insults. We therefore set out to examine the influence of heat shock protein 70 on the incidence of postoperative atrial fibrillation.
We prospectively recruited 80 patients undergoing elective coronary artery bypass surgery. Blood samples were collected preoperatively. Right atrial tissue was obtained at surgery. Incidence of postoperative atrial fibrillation and its duration were noted. Using a nested case-control design, 15 patients who developed atrial fibrillation were matched for operative procedure, age, sex, and beta-blocker usage, with 15 controls from the remaining patients. Atrial heat shock protein 70 was subsequently quantified by immunohistochemistry. Serum heat shock protein was measured using enzyme-linked immunosorbent assay and high sensitivity C-reactive protein was determined by immunoturbidometric assay.
Intracellular HSP70 level was significantly higher in patients who did not develop atrial fibrillation (35 +/- 13 vs 19 +/- 15; p = 0.006). Atrial HSP70 level negatively correlated with atrial fibrillation; independent of other risk factors (odds ratio = 0.90; 95% confidence interval 0.84 to 0.99, p = 0.02). Serum HSP70 levels were similar in both groups (p = 0.81) and did not correlate with intracellular levels (p = 0.38). Preoperative C-reactive protein levels were similar in both groups (p = 0.93).
Intracellular, but not serum, HSP70 level is negatively correlated with postoperative atrial fibrillation. This suggests a cardioprotective and an antiarrhythmic role for intracellular HSP70.
心房颤动是心脏手术后常见的心律失常。心脏手术相关的再灌注损伤和炎症被认为参与了其发病机制。我们假设与热休克蛋白70(HSP70)相关的细胞保护作用可以抵消这些促心律失常的损伤。因此,我们着手研究热休克蛋白70对术后心房颤动发生率的影响。
我们前瞻性招募了80例行择期冠状动脉搭桥手术的患者。术前采集血样。手术时获取右心房组织。记录术后心房颤动的发生率及其持续时间。采用巢式病例对照设计,将15例发生心房颤动的患者与其余患者中的15例对照者在手术方式、年龄、性别和β受体阻滞剂使用情况方面进行匹配。随后通过免疫组织化学法定量检测心房热休克蛋白70。采用酶联免疫吸附测定法测量血清热休克蛋白,并通过免疫比浊法测定高敏C反应蛋白。
未发生心房颤动的患者细胞内HSP70水平显著更高(35±13 vs 19±15;p = 0.006)。心房HSP70水平与心房颤动呈负相关;独立于其他危险因素(比值比 = 0.90;95%置信区间0.84至0.99,p = 0.02)。两组血清HSP70水平相似(p = 0.81),且与细胞内水平无关(p = 0.38)。两组术前C反应蛋白水平相似(p = 0.93)。
细胞内而非血清中的HSP70水平与术后心房颤动呈负相关。这表明细胞内HSP70具有心脏保护和抗心律失常作用。